Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer
Introduction
The axillary lymph node (ALN) status is one of the most important prognostic factors in newly diagnosed breast cancer patients.1 The preoperative recognition of ALN positivity is important for deciding on the surgical approach for the ALN.2, 3, 4
Preoperative lymph node staging has been introduced using various modalities including ultrasonography (US), computed tomography, magnetic resonance imaging, and positron emission tomography.5, 6, 7 Positron emission tomography with 18F-fluorodeoxyglucose (FDG-PET) has been used for the diagnosis and management of breast cancer.5 Although several early studies on FDG-PET for axillary staging showed both high sensitivities and specificities, low sensitivities for PET have been reported in most studies, especially in patients with small primary tumors.5, 8
Ultrasonography (US) is widely performed for the preoperative diagnosis of breast cancer. US in combination with US-guided percutaneous fine needle aspiration cytology (US-guided FNAC) has also provided accurate results for determining the ALN status, providing a moderate sensitivity and a high specificity for the preoperative assessment of ALN.2, 9, 10, 11
Although a few studies have reported the use of FDG-PET or FDG-PET/CT in combination with US for axillary staging in primary breast cancer,12, 13 studies evaluating FDG-PET/CT in combination with US-guided FNAC for preoperative axillary staging have not been described. The aim of the present study was to assess the diagnostic performance of FDG-PET/CT in combination with US-guided FNAC for the preoperative diagnosis of ALN metastases of breast cancer.
Section snippets
Patients
The study protocol was approved by the local ethics committee. Patients who underwent surgery for breast cancer between December 2005 and November 2009 at our institution were reviewed retrospectively. During the study period, 318 cases with breast cancer underwent preoperative FDG-PET/CT. Some of these patients had undergone neoadjuvant chemotherapy (NAC) prior to axillary surgery. Patients, whose initial ALN statuses were unclear, because of the effect of NAC, were excluded from the present
Patient characteristics
Of the 318 cases, 227 underwent surgery without NAC and the other 91 cases underwent NAC prior to surgery. Among the cases with NAC, ALN metastases were identified by FNAC prior to NAC in 13 cases and based on the histopathological analysis in 31 cases. These cases were included in the present study. The remaining 47 cases with NAC were excluded from the analysis because their initial ALN statuses were unknown. A total of 271 cases, 227 without NAC and 44 with NAC, were enrolled in the present
Performance of FDG-PET/CT
The specificity of PET for axillary staging has been consistently high in previous reports, ranging from 75% to 100%.5 In the present study, the specificity of FDG-PET/CT among the cases without NAC was also high. On the other hand, the sensitivity was 40.8% overall, indicating that more than half of all patients with ALN metastases are overlooked. The sensitivity of FDG-PET/CT decreased to 18.5% for the cases without NAC, probably because the cases without NAC had an early stage than those
Conclusion
In conclusion, FDG-PET/CT has a good specificity for ALN metastasis, although its sensitivity is limited, especially in early-stage cases. In cases with a negative FDG uptake in the ALN, US-guided FNAC may play a role in the detection of lymph node metastasis when the primary tumor size is large and FDG uptake in the primary tumor is low.
Conflict of interest
The authors declare that there are no conflicts of interest.
References (15)
- et al.
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
Lancet
(1997 Jun 28) - et al.
Ultrasound and fine needle aspiration cytology of the axilla in the pre-operative identification of axillary nodal involvement in breast cancer
Eur J Surg Oncol
(2009) - et al.
Prognostic and predictive factors on early-stage breast cancer
Oncologist
(2004) - et al.
Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer–correlation with primary tumor size
Radiology
(2008) - et al.
Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy – clinical experience in 100 patients
Radiology
(2009 Jan) - et al.
A systematic review of FDG-PET in breast cancer
Med Oncol
(2010 Mar) - et al.
Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review
AJR Am J Roentgenol
(2006 May)
Cited by (18)
Axillary lymph node status in breast cancer patients: Preoperative assessment and management's evolution
2017, Imagerie de la FemmeComparison between<sup>18</sup>F-FDG PET/CT and diffusion-weighted imaging in detection of invasive ductal breast carcinoma
2024, Asia Oceania Journal of Nuclear Medicine and BiologyPretherapeutic imaging for axillary staging in breast cancer: A systematic review and meta-analysis of ultrasound, mri and fdg pet
2021, Journal of Clinical Medicine